← All candidates
One insider buy in the last year — $98.8K in all.
28 filings on record.
MLTXMoonLake Immunotherapeutics
NasdaqCM · Healthcare · $1.06B
$12.51
-5.08% · Sep 11
One insider buy in the last year — $98.8K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 15 sells◆ 7 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.06B
Float
55.5M
65% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Financial Officer
Bodenstedt Matthias
Bought $98.8K on Oct 8 — 10,870 sh @ $9.09, held direct, 1.7% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
22 more transactions on Pro →The file stays open
28 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice